Key Roles

• Director. Innovative Medicine Special Fund, China Scholarship Development Foundation.
• Immune Cell Therapy Innovator
• Published landmark cover study in Nature Immunology (2004), revealing immune microenvironment’s role in reversing dendritic cell dysfunction.
• Discovered CD8+vNKT cells (2002), a unique immune subpopulation with bidirectional anti-tumor effects.

Clinical Breakthroughs

• Developed vNKT cell therapy for advanced solid tumors:
• 80%+ 5-year tumor-free rate in Stage III patients.
• 40%+ 5-year tumor-free rate in Stage IV colorectal cancer with metastasis (combined with minimally invasive surgery).

Chronic Disease Innovations

• Non-Chemical Therapies
• Leveraged mesenchymal stem cells (MSCs) and gut microbiota modulation to treat
• Type 2 diabetes, Hashimoto’s thyroiditis, inflammatory bowel disease (IBD).
• Alzheimer’s disease, stroke sequelae (achieving functional reversal in some cases).
• Founder : Established Lehe New Medical Chronic Disease Rehabilitation Center integrating research, diagnosis, and holistic care for chronic conditions.

Academic & Clinical Impact

• Bridged foundational immunology with translational applications, redefining standards in oncology and chronic disease management.
• Global leader in advancing precision immune therapies and regenerative medicine.